CY1107939T1 - Συνεργικοι φαρμακευτικοι συνδυασμοι για την προληψη ή την αγωγη του διαβητη - Google Patents
Συνεργικοι φαρμακευτικοι συνδυασμοι για την προληψη ή την αγωγη του διαβητηInfo
- Publication number
- CY1107939T1 CY1107939T1 CY20081100487T CY081100487T CY1107939T1 CY 1107939 T1 CY1107939 T1 CY 1107939T1 CY 20081100487 T CY20081100487 T CY 20081100487T CY 081100487 T CY081100487 T CY 081100487T CY 1107939 T1 CY1107939 T1 CY 1107939T1
- Authority
- CY
- Cyprus
- Prior art keywords
- prevention
- diabetes
- synoptic
- treatment
- medicinal drugs
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 239000012050 conventional carrier Substances 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 230000003178 anti-diabetic effect Effects 0.000 abstract 1
- 230000001315 anti-hyperlipaemic effect Effects 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0102982A HU0102982D0 (en) | 2001-07-17 | 2001-07-17 | Synergic pharmaceutical composition |
| HU0202204A HU226244B1 (hu) | 2002-07-05 | 2002-07-05 | Gyógyszer-kombináció a diabétesz megelõzésére vagy kezelésére |
| EP02751454A EP1408966B1 (en) | 2001-07-17 | 2002-07-10 | Synergistic pharmaceutical combinations for the prevention or treatment of diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1107939T1 true CY1107939T1 (el) | 2013-09-04 |
Family
ID=89980599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20081100487T CY1107939T1 (el) | 2001-07-17 | 2008-05-08 | Συνεργικοι φαρμακευτικοι συνδυασμοι για την προληψη ή την αγωγη του διαβητη |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US7635674B2 (https=) |
| EP (1) | EP1408966B1 (https=) |
| JP (1) | JP4598390B2 (https=) |
| KR (1) | KR100920560B1 (https=) |
| CN (1) | CN1270713C (https=) |
| AT (1) | ATE386523T1 (https=) |
| AU (1) | AU2002354884B2 (https=) |
| BR (1) | BR0210744A (https=) |
| CA (2) | CA2682251A1 (https=) |
| CY (1) | CY1107939T1 (https=) |
| DE (1) | DE60225143T2 (https=) |
| DK (1) | DK1408966T3 (https=) |
| ES (1) | ES2300460T3 (https=) |
| IL (2) | IL159412A0 (https=) |
| MX (1) | MXPA04000324A (https=) |
| NO (1) | NO20040153L (https=) |
| NZ (1) | NZ531155A (https=) |
| PL (1) | PL205826B1 (https=) |
| PT (1) | PT1408966E (https=) |
| RU (1) | RU2311907C2 (https=) |
| WO (1) | WO2003007951A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006044531A2 (en) * | 2004-10-13 | 2006-04-27 | Isis Parmaceuticals, Inc. | Antisense modulation of ptp1b expression |
| US20080108602A1 (en) * | 2006-11-02 | 2008-05-08 | N-Gene Research Laboratories, Inc. | Prevention of obesity in antipsychotic, antidepressant and antiepileptic medication |
| US7763601B2 (en) * | 2006-11-02 | 2010-07-27 | N-Gene Research Laboratories, Inc. | Prevention and treatment of obesity |
| ES2355680T3 (es) * | 2006-11-02 | 2011-03-30 | N-Gene Research Laboratories Inc. | Reducción del sobrepeso o de la obesidad. |
| ZA200902761B (en) * | 2006-11-02 | 2010-07-28 | N Gene Res Lab Inc | A pharmaceutical composition having antipsychotic, antidepressant or antiepileptic activity with reduced side effect |
| US20080208328A1 (en) * | 2007-02-23 | 2008-08-28 | Endovalve, Inc. | Systems and Methods For Placement of Valve Prosthesis System |
| CN101801351B (zh) | 2007-07-19 | 2012-12-12 | 武田药品工业株式会社 | 包含阿格列汀和盐酸二甲双胍的固体制剂 |
| PT2868315T (pt) * | 2007-12-04 | 2017-09-04 | Remedy Pharmaceuticals Inc | Formulações melhoradas e métodos para liofilização e liofilizados assim produzidos |
| US20090281143A1 (en) * | 2007-12-10 | 2009-11-12 | N-Gene Research Laboratories, Inc. | Dose Reduction of a Cannabinoid CB1 Receptor Antagonist in the Treatment of Overweight or Obesity |
| WO2012142458A1 (en) | 2011-04-13 | 2012-10-18 | Isis Pharmaceuticals, Inc. | Antisense modulation of ptp1b expression |
| HUP1100445A2 (en) | 2011-08-17 | 2013-02-28 | Pharma Gene Sa | Pharmaceutical composition |
| HUP1100444A2 (en) | 2011-08-17 | 2013-02-28 | Pharma Gene Sa | Pharmaceutical composition |
| CN105476995A (zh) * | 2015-12-23 | 2016-04-13 | 青岛海之源智能技术有限公司 | 一种二甲双胍阿昔莫司复方缓释胶囊及制备方法 |
| KR102642823B1 (ko) | 2017-06-30 | 2024-03-04 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 모발 성장을 조절하기 위한 조성물 및 방법 |
| HUP1800298A1 (hu) | 2018-08-30 | 2020-05-28 | N Gene Res Laboratories Inc | Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére |
| CN115916202A (zh) * | 2020-05-27 | 2023-04-04 | 科赛普特治疗学股份有限公司 | 糖皮质激素受体调节剂瑞拉可兰和cyp2c9底物的并行给药 |
| EP4172159A4 (en) | 2020-06-30 | 2024-01-10 | The Regents of the University of California | Compositions and methods for modulating hair growth |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4308399A (en) * | 1977-08-30 | 1981-12-29 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. | O-(3-Amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| HU207988B (en) * | 1988-10-20 | 1993-07-28 | Biorex Kutato Fejlesztoe Kft | Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components |
| US5190970A (en) * | 1990-10-19 | 1993-03-02 | E. R. Squibb & Sons, Inc. | Method for preventing onset of or treating Type II diabetes employing a cholesterol lowering drug alone or in combination with an ace inhibitor |
| US6011049A (en) * | 1997-02-19 | 2000-01-04 | Warner-Lambert Company | Combinations for diabetes |
| US6153632A (en) * | 1997-02-24 | 2000-11-28 | Rieveley; Robert B. | Method and composition for the treatment of diabetes |
| US6291495B1 (en) * | 1997-02-24 | 2001-09-18 | Robert B. Rieveley | Method and composition for the treatment of diabetes |
| US6121278A (en) * | 1997-09-03 | 2000-09-19 | Guilford Pharmaceuticals, Inc. | Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity |
| AU5296799A (en) * | 1998-08-03 | 2000-02-28 | N-Gene Kutato Kft. | Pharmaceutical compositions against autoimmune diseases |
| UA65635C2 (uk) * | 1998-09-03 | 2004-04-15 | Н-Гене Кутато Кфт. | НЕНАСИЧЕНІ ПОХІДНІ ГІДРОКСИМОВОЇ КИСЛОТИ, ЩО МАЮТЬ ВЛАСТИВОСТІ ІНГІБІТОРІВ NAD<sup>+</sup>-ADP-РИБОЗИЛТРАНСФЕРАЗИ |
-
2002
- 2002-07-10 BR BR0210744-9A patent/BR0210744A/pt active Search and Examination
- 2002-07-10 RU RU2004105149/15A patent/RU2311907C2/ru not_active IP Right Cessation
- 2002-07-10 NZ NZ531155A patent/NZ531155A/en not_active IP Right Cessation
- 2002-07-10 PT PT02751454T patent/PT1408966E/pt unknown
- 2002-07-10 WO PCT/HU2002/000067 patent/WO2003007951A1/en not_active Ceased
- 2002-07-10 EP EP02751454A patent/EP1408966B1/en not_active Expired - Lifetime
- 2002-07-10 ES ES02751454T patent/ES2300460T3/es not_active Expired - Lifetime
- 2002-07-10 CA CA002682251A patent/CA2682251A1/en not_active Abandoned
- 2002-07-10 AT AT02751454T patent/ATE386523T1/de active
- 2002-07-10 CA CA002452558A patent/CA2452558C/en not_active Expired - Fee Related
- 2002-07-10 DE DE60225143T patent/DE60225143T2/de not_active Expired - Lifetime
- 2002-07-10 AU AU2002354884A patent/AU2002354884B2/en not_active Ceased
- 2002-07-10 JP JP2003513558A patent/JP4598390B2/ja not_active Expired - Fee Related
- 2002-07-10 PL PL364662A patent/PL205826B1/pl unknown
- 2002-07-10 KR KR1020047000748A patent/KR100920560B1/ko not_active Expired - Fee Related
- 2002-07-10 IL IL15941202A patent/IL159412A0/xx unknown
- 2002-07-10 MX MXPA04000324A patent/MXPA04000324A/es active IP Right Grant
- 2002-07-10 CN CNB02814340XA patent/CN1270713C/zh not_active Expired - Fee Related
- 2002-07-10 US US10/495,240 patent/US7635674B2/en not_active Expired - Fee Related
- 2002-07-10 DK DK02751454T patent/DK1408966T3/da active
-
2003
- 2003-12-17 IL IL159412A patent/IL159412A/en not_active IP Right Cessation
-
2004
- 2004-01-13 NO NO20040153A patent/NO20040153L/no not_active Application Discontinuation
-
2008
- 2008-05-08 CY CY20081100487T patent/CY1107939T1/el unknown
-
2009
- 2009-11-06 US US12/614,225 patent/US8048873B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1107939T1 (el) | Συνεργικοι φαρμακευτικοι συνδυασμοι για την προληψη ή την αγωγη του διαβητη | |
| ATE339406T1 (de) | Chinazoline verbindungen als heilmittel | |
| DE69529670D1 (de) | Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen | |
| DE50311898D1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
| DE60142891D1 (de) | Azetidinderivate enthaltende pharmazeutische zusammensetzungen, die azetidinderivate und deren herstellung | |
| CY1107966T1 (el) | Φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν μετφορμινη και γλιβενκλαμιδη για τη θεραπεια του σακχαρωδους διαβητη τυπου ii | |
| CY1108823T1 (el) | Παραγωγα 2-υδροξυ-3-ετεροαρυλινδολης ως αναστολεις της gsk3 | |
| DE60034240D1 (de) | Drogen zur behandlung maligner tumoren | |
| BR0316771A (pt) | Compostos para o tratamento ou a prevenção de infecções por flavivirus, uso de um composto e composição farmacêutica | |
| BR0116370A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente. | |
| CY1107675T1 (el) | Φαρμακευτικα αλατα τραμαδολης | |
| BR0114310A (pt) | Derivados do glicopiranosiloxibenzilbenzeno e composições medicinais contendo os mesmos | |
| BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
| BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
| NO20052908D0 (no) | Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents. | |
| PT1251846E (pt) | Taxanos com carbonato c-4 | |
| BR0107628A (pt) | l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial | |
| ECSP045405A (es) | Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa | |
| DE60023154D1 (de) | Alkoxy-substituierte benzimidazolverbindungen , diese enthaltende arzneimittel und ihre verwendung | |
| BR0211223A (pt) | Derivados de 4-aminociclohexanol substituìdos | |
| BR0206841A (pt) | Modificação cristalina de um depsipeptìdeo cìclico com melhor eficácia | |
| SE0004827D0 (sv) | Therapeutic compounds | |
| BR0308911A (pt) | Composto, composição farmacêutica, métodos de tratamento de dor e de enxaqueca, e, uso de um composto | |
| RU2217420C1 (ru) | 2-r-7а-метил-3-(спироциклогекса-2,5-диен-4-он)-пергидроиндолины-1 | |
| BR0211026A (pt) | Medicamentos que contem derivados de tetrahidroquinolina |